Safety of OTC Cough Medicine with Vyvanse

Primary Drug Interaction Concern

The American Academy of Allergy, Asthma, and Immunology recommends avoiding oral decongestants (pseudoephedrine, phenylephrine) combined with stimulant medications like Vyvanse due to increased stimulatory effects resulting in tachyarrhythmias, insomnia, and hyperactivity 1

Pseudoephedrine and phenylephrine should be strictly avoided when taking Vyvanse due to additive sympathomimetic effects 1
Between 1969-2006, there were 54 fatalities associated with decongestants in children, highlighting their potential toxicity even without concurrent stimulant use 2
Combination products containing both antihistamines and decongestants pose dual risks and should be avoided 1, 2
These combinations have not been proven effective for cough and carry unnecessary risk 2
Diphenhydramine, brompheniramine, and chlorpheniramine were associated with 69 fatalities between 1969-2006 2
While the interaction with Vyvanse is less direct than with decongestants, these can cause sedation that may mask stimulant side effects 1

Central-acting antitussives (dextromethorphan, codeine) may be used for short-term symptomatic relief as they do not have significant interactions with stimulant medications 3
Hypertonic saline solution can increase cough clearance without drug interactions 3
The huffing technique should be taught as an adjunct for sputum clearance 3

The FDA's advisory committees recommended in 2007 that OTC cough and cold medications should not be used in children below 6 years of age due to lack of efficacy and safety concerns 1, 2

If cough is present with Vyvanse use, avoid all products containing decongestants (pseudoephedrine, phenylephrine) 1
Consider dextromethorphan-only products (no decongestant) for short-term use 3
Use hypertonic saline as first-line non-pharmacologic option 3
If cough persists beyond 1-2 weeks, evaluate for underlying causes rather than continuing OTC medications 3
Consider prescription options like inhaled ipratropium bromide 3